| Literature DB >> 25904939 |
Koji Takemoto1, Richard J Deckelbaum2, Isao Saito3, Supawadee Likitmaskul4, Anita Morandi5, Leonardo Pinelli5, Eiichi Ishii1, Kaichi Kida1, Marwah Abdalla6.
Abstract
BACKGROUND: There are few reports on the effects of ethnicity or gender in the association between adipocytokines and insulin resistance in children of different ages. This study assessed associations between serum concentrations of adiponectin/resistin and parameters of insulin resistance in children from 4 different countries.Entities:
Keywords: Adiponectin; Insulin resistance; Metabolic syndrome; Resistin
Year: 2015 PMID: 25904939 PMCID: PMC4406215 DOI: 10.1186/1687-9856-2015-2
Source DB: PubMed Journal: Int J Pediatr Endocrinol ISSN: 1687-9848
Baseline clinical characteristics of group 1 children from Japan, Italy, and the USA
| Males | Females | |||||
|---|---|---|---|---|---|---|
| Japan | Italy | USA | Japan | Italy | USA | |
| n | 411 | 220 | 55 | 341 | 164 | 43 |
| Age | 9.5 ± 0.0 | 9.4 ± 0.0 | 9.2 ± 0.1 | 9.6 ± 0.0 | 9.6 ± 0.0 | 9.6 ± 0.2 |
| Height (cm) | 135.4 ± 0.3a,b | 138.3 ± 0.5 | 138.0 ± 1.3 | 135.9 ± 0.4a,b | 138.8 ± 0.6c | 143.2 ± 1.4 |
| Weight (kg) | 32.8 ± 0.4a,b | 34.8 ± 0.5c | 41.0 ± 1.9 | 32.1 ± 0.4a,b | 34.5 ± 0.5c | 43.2 ± 1.9 |
| BMI | 17.7 ± 0.2b | 18.0 ± 0.2c | 21.1 ± 0.7 | 17.2 ± 0.1a,b | 17.9 ± 0.2c | 20.8 ± 0.7 |
| Waist (cm) | 60.6 ± 0.9 | NT | 68.6 ± 12.0 | 58.2 ± 0.4 | NT | 67.1 ± 12.1 |
| Systolic B.P. (mmHg) | 108 ± 0.7a,b | 99.0 ± 0.9c | 113 ± 1.5 | 109 ± 0.7a,b | 98 ± 0.8c | 115 ± 1.4 |
| Diastolic B.P. (mmHg) | 58 ± 0.4 | 58 ± 0.8 | 60 ± 1.2 | 58 ± 0.4b | 59 ± 0.8c | 64 ± 1.2 |
| HDL-C (mg/dl) | 66.5 ± 0.6a,b | 61.5 ± 0.8c | 45.1 ± 1.5 | 65.0 ± 0.6a,b | 60.2 ± 0.8c | 48.3 ± 3.5 |
| TG (mg/dl) | 67.1 ± 2.2a,b | 52.8 ± 2.1c | 105.0 ± 6.5 | 75.8 ± 2.3a,b | 61.7 ± 2.2c | 116.9 ± 7.6 |
| Insulin (μU/ml) | 6.1 ± 0.6a,b | 9.6 ± 0.4 | 11.2 ± 2.0 | 7.9 ± 0.5a,b | 12.0 ± 0.5c | 18.0 ± 2.5 |
| Glucose (mg/dl) | 91.1 ± 0.5a | 87.9 ± 0.6 | 90.1 ± 0.9 | 90.3 ± 0.5b | 86.7 ± 0.5 | 89.1 ± 1.5 |
| HOMA-IR | 1.41 ± 0.15a,b | 2.11 ± 0.10 | 2.51 ± 0.45 | 1.79 ± 0.11a,b | 2.59 ± 0.12c | 4.16 ± 0.6 |
| Adiponectin (μg/ml) | 12.0 ± 0.4a,b | 14.0 ± 0.4 | 14.0 ± 0.7 | 13.2 ± 0.4a | 14.9 ± 0.4 | 14.6 ± 1.0 |
| Resistin (μg/ml) | 9.1 ± 0.5 | 10.1 ± 0.3c | 8.4 ± 0.3 | 10.6 ± 0.5 | 10.8 ± 0.3 | 9.1 ± 0.6 |
Each value indicates mean ± S.E. (standard error).
Analysis of variance (ANOVA) was used to compare all parameters among children from different countries.
The a, b, c mean p < 0.05 between Japan and Italy (a), Japan and USA (b), and Italy and USA (c).
BMI, body mass index; B.P., blood pressure; HDL-C, high-density lipoprotein-cholesterol; TG, triglycerides; HOMA-IR, homeostasis model assessment of insulin resistance; NT, not tested.
Baseline clinical characteristics of group 2 children from Japan, Thailand, Italy, and the USA
| Males | Females | |||||||
|---|---|---|---|---|---|---|---|---|
| Japan | Thailand | Italy | USA | Japan | Thailand | Italy | USA | |
| n | 97 | 247 | 168 | 45 | 85 | 223 | 144 | 45 |
| Age | 12.5 ± 0.1 | 13.1 ± 0.0 | 12.3 ± 0.0 | 13.1 ± 0.2 | 12.6 ± 0.1 | 13.0 ± 0.0 | 12.3 ± 0.0 | 13.3 ± 0.2 |
| Height (cm) | 155.6 ± 0.8b,c | 159.2 ± 0.5 | 154.9 ± 0.7d | 159.6 ± 2.0 | 153.2 ± 0.6c | 154.0 ± 0.4 | 154.9 ± 0.6 | 156.5 ± 1.0 |
| Weight (kg) | 45.6 ± 1.0b,c | 55.3 ± 0.9 | 48.9 ± 0.9d,e | 58.1 ± 2.6 | 44.4 ± 1.0b,c | 49.9 ± 0.9f | 46.7 ± 0.8e | 58.4 ± 2.5 |
| BMI | 18.7 ± 0.3a,b,c | 21.8 ± 0.3 | 20.2 ± 0.3d,e | 22.4 ± 0.7 | 18.8 ± 0.3b,c | 21.0 ± 0.3f | 19.3 ± 0.2e | 23.6 ± 0.9 |
| Waist (cm) | 66.4 ± 0.8 | 76.8 ± 13.0 | NT | 68.6 ± 12.0 | 61.8 ± 1.0 | 68.4 ± 10.0 | NT | 67.1 ± 12.1 |
| Systolic B.P. (mmHg) | 112 ± 1.5b,c | 116 ± 0.8f | 110. ± 1.0d,e | 122 ± 1.4 | 109 ± 1.5c | 111 ± 0.7 | 108 ± 1.2e | 115 ± 1.5 |
| Diastolic B.P. (mmHg) | 60 ± 0.8b,c | 68 ± 0.6f | 60 ± 0.7d,e | 64 ± 1.1 | 59 ± 0.9a,b | 69 ± 0.5f | 62 ± 0.9d | 62 ± 1.0 |
| HDL-C (mg/dl) | 64.6 ± 1.4b,c | 60.6 ± 0.8f | 60.9 ± 0.9e | 41.8 ± 1.2 | 64.0 ± 1.3a,b,c | 60.4 ± 0.8f | 59.5 ± 0.8e | 42.2 ± 1.5 |
| TG (mg/dl) | 57.4 ± 3.4a,b,c | 73.5 ± 2.8f | 57.3 ± 2.6d,e | 105.0 ± 6.5 | 69.4 ± 3.3c | 70.8 ± 1.8f | 66.1 ± 2.3e | 111.9 ± 7.7 |
| Insulin (μU/ml) | 8.3 ± 0.6a,c | 10.1 ± 0.7f | 12.8 ± 0.8d | 14.3 ± 1.4 | 9.0 ± 0.6a,c | 9.0 ± 0.5f | 15.5 ± 0.6d,e | 23.1 ± 2.8 |
| Glucose (mg/dl) | 92.8 ± 0.6 | 92.6 ± 0.4 | 90.5 ± 6.0d | 91.7 ± 1.2 | 92.9 ± 0.7a,b,c | 89.5 ± 0.5 | 89.5 ± 0.5 | 89.2 ± 1.0 |
| HOMA-IR | 1.95 ± 0.15a,c | 2.35 ± 0.18f | 2.91 ± 0.19 | 3.28 ± 0.33 | 2.10 ± 0.15a,c | 2.03 ± 0.13f | 3.45 ± 0.14d,e | 5.26 ± 0.7 |
| Adiponectin (μg/ml) | 10.7 ± 0.5a | 10.2 ± 0.4f | 12.8 ± 0.4d | 13.0 ± 1.0 | 11.0 ± 0.4a,c | 12.0 ± 0.4 | 13.6 ± 0.4d | 13.2 ± 1.0 |
| Resistin (μg/ml) | 14.8 ± 0.8a,b,c | 19.4 ± 1.3f | 9.9 ± 0.3d | 9.1 ± 0.6 | 16.4 ± 1.2a,c | 20.4 ± 1.6f | 11.3 ± 0.4d | 10.3 ± 0.6 |
Each value indicates mean ± S.E. (standard error).
Analysis of variance (ANOVA) was used to compare all parameter levels among children from different countries.
The a, b, c, d, e, f mean p < 0.05 between Japan and Italy (a), Japan and Thailand (b), Japan and USA (c), Italy and Thailand (d), Italy and USA (e), and Thailand and USA (f).
BMI, body mass index; B.P., blood pressure; HDL-C, high-density lipoprotein-cholesterol; TG, triglycerides; HOMA-IR, homeostasis model assessment of insulin resistance; NT, not tested.
Figure 1Serum adiponectin (A and B) and resistin (C and D) concentration in children divided into Groups 1 and 2 according to sex and country of origin. A: Serum adiponectin concentration in Group 1, B: Serum adiponectin concentration in Group 2, C: Serum resistin concentration in Group 1, D: Serum resistin concentration in Group 2. White squares indicate female children, and gray squares indicate male children. #p < 0.05 indicate significant levels in children from Japan compared to those from other countries. * *p < 0.05 indicate significant differences in male children compared to female children. Analysis of variance (ANOVA) was used to compare adipocytokine levels among children from different countries. Student’s t-tests were used to compare adipocytokine levels between male and female children and between Group 1 and Group 2.
Correlation coefficients between adiponectin, resistin and selected parameters related to metabolic syndrome and insulin resistance
| Males | Group 1 | Group 2 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adiponectin | Resistin | Adiponectin | Resistin | |||||||||||
| Japan | Italy | USA | Japan | Italy | USA | Japan | Thailand | Italy | USA | Japan | Thailand | Italy | USA | |
|
| −0.117 | −0.143 | −0.236 | 0.072 | 0.154 | 0.139 | −0.339* | −0.455* | −0.243* | −0.487* | 0.032 | 0.054 | 0.216* | −0.066 |
|
| −0.121 | - | −0.135 | 0.092 | - | 0.226 | −0.3* | −0.454* | - | −0451* | 0.035 | 0.081 | - | −0.176 |
|
| −0.064 | 0.029 | 0.003 | 0.049 | 0.206* | 0.289* | −0.213* | −0.206* | 0.071 | −0.303* | −0.231* | 0.008 | 0.098 | −0.156 |
|
| −0.053 | 0.132 | 0.114 | 0.153 | 0.182* | 0.126 | −0.043 | 0.184* | 0.005 | 0.229 | −0.024 | −0.006 | −0.051 | 0.026 |
|
| 0.25* | 0.417* | 0.284* | −0.05 | −0.157 | −0.164 | 0.346* | 0.389* | 0.260* | 0.282 | 0.013 | −0.032 | −0.083 | −0.210 |
|
| −0.166 | −0.215* | −0.347* | 0.085 | 0.182* | 0.253 | −0.24* | −0.27* | −0.087 | 0.013 | −0.082 | −0.003 | 0.098 | 0.079 |
|
| −0.143 | −0.088 | −0.188 | −0.001 | 0.122 | 0.147 | −0.179 | −0.394* | −0.196* | −0.475* | −0.094 | 0.049 | 0.088 | −0.228 |
|
| −0.157 | −0.078 | −0.207 | −0.003 | 0.126 | 0.131 | −0.189 | −0.389* | −0.176 | −0.471* | −0.116 | 0.028 | 0.110 | −0.263 |
|
|
|
| ||||||||||||
|
|
|
|
| |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| −0.196* | −0.196* | −0.498* | 0.095 | 0.228* | 0.224 | −0.486* | −0.478* | −0.047 | −0.303* | −0.018 | 0.289* | 0.143 | 0.115 |
|
| −0.263+ | - | −0.483* | −0.003 | - | 0.174 | −0.45* | −0.501* | - | −0.163 | 0.002 | 0.14 | - | 0.043 |
|
| −0.017 | −0.023 | −0.361* | 0.209* | 0.241* | −0.023 | −0.232* | −0.384* | 0.018 | −0.011 | −0.044 | 0.206* | 0.165 | 0.031 |
|
| 0.224* | −0.031 | −0.051 | 0.126 | 0.177 | −0.165 | −0.161 | −0.136 | −0146 | −0.125 | −0.027 | 0.106 | 0.123 | 0.047 |
|
| 0.234* | 0.352* | 0.213 | 0.106 | −0.102 | −0.049 | 0.293* | 0.274* | 0.113 | 0.414* | −0.069 | −0.075 | −0.166 | 0.100 |
|
| −0.207* | −0.105 | 0.014 | −0.100 | 0.16 | −0.162 | −0.265* | −0.136 | −0.2* | −0.02 | 0.09 | 0.007 | 0.073 | 0.025 |
|
| −0.239* | −0.212* | −0.33* | 0.001 | 0.268* | −0.044 | −0.386* | −0.478* | −0.217* | −0.076 | 0.133 | 0.112 | 0.106 | −0.079 |
|
| −0.247* | −0.199* | −0.346* | 0.015 | 0.256* | 0.001 | −0.397* | −0.475* | −0.227* | −0.067 | 0.155 | 0.125 | 0.103 | −0.117 |
Each value represents the correlation coefficient between two parameters. p-values are as follows; *p < 0.05.
BMI, body mass index; B.P., blood pressure; HDL-C, high-density lipoprotein-cholesterol; TG, triglycerides; HOMA-IR, homeostasis model assessment of insulin resistance.
Regression coefficients between HOMA-IR and anthropometric parameters, serum lipids and adipocytokines in multiple regression analyses
| Males | Group 1 | Group 2 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Japan | Italy | USA | Japan | Thailand | Italy | USA | ||||||||
| β | p | β | p | β | p | β | p | β | p | β | p | β | p | |
|
| 0.464 | <0.001* | 0.293 | 0.01* | 0.381 | 0.004 | 0.322 | 0.003* | 0.365 | <0.001* | 0.578 | 0.006* | 0.245 | 0.176 |
|
| 0.162 | 0.041* | 0.015 | 0.079 | 0.116 | 0.334 | 0.036 | 0.706 | 0.244 | 0.002* | 0.046 | 0.002* | 0.139 | 0.412 |
|
| 0.140 | 0.086 | 0.003 | 0.294 | 0.394 | 0.007 | 0.443 | <0.001* | 0.234 | 0.005* | 0.014 | 0.023* | −0.020 | 0.899 |
|
| −0.128 | 0.128 | −0.061 | 0.882 | 0.265 | 0.054 | 0.064 | 0.533 | −0.007 | 0.928 | 0.003 | 0.844 | −0.044 | 0.792 |
|
| −0.029 | 0.708 | −0.008 | 0.716 | −0.082 | 0.504 | 0.019 | 0.836 | −0.062 | 0.430 | −0.083 | 0.04* | −0.291 | 0.078 |
|
| −0.042 | 0.578 | 0.015 | 0.611 | 0.039 | 0.744 | −0.112 | 0.197 | −0.035 | 0.607 | −0.064 | 0.312 | −0.112 | 0.485 |
|
|
|
| ||||||||||||
|
|
|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| 0.318 | <0.001* | 0.337 | 0.009* | 0.425 | 0.010* | 0.094 | 0.367 | 0.343 | 0.001* | 0.403 | 0.005* | 0.347 | 0.028* |
|
| 0.153 | 0.072 | 0.007 | 0.544 | 0.151 | 0.321 | 0.278 | 0.012* | 0.157 | 0.086 | 0.001 | 0.952 | 0.131 | 0.405 |
|
| 0.264 | 0.002* | 0.014 | 0.001* | 0.206 | 0.207 | 0.092 | 0.396 | 0.126 | 0.102 | 0.013 | 0.012* | −0.180 | 0.249 |
|
| −0.134 | 0.111 | 0.017 | 0.187 | −0.074 | 0.645 | −0.088 | 0.445 | 0.120 | 0.132 | 0.015 | 0.314 | −0.455 | 0.006* |
|
| −0.082 | 0.321 | −0.043 | 0.115 | −0.187 | 0.202 | −0.299 | 0.010* | −0.179 | 0.052 | −0.071 | 0.025* | 0.278 | 0.065 |
|
| −0.034 | 0.680 | 0.025 | 0.424 | −0.070 | 0.619 | 0.141 | 0.166 | 0.041 | 0.599 | 0.031 | 0.293 | −0.103 | 0.461 |
Each value means the b- and p-value between HOMA-IR and each factor; *p < 0.05.
**In Italy, the data of BMI Z-scores was used rather than the data of waist.
BMI, body mass index; B.P., blood pressure; HDL-C, high-density lipoprotein-cholesterol; TG, triglycerides; HOMA-IR, homeostasis model assessment of insulin resistance.